Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | UTI | UTI |
| NAV | ₹230.3012 | ₹95.8087 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 3.2 years | 7.7 years |
| Expense ratio | 0.0% | 0.0% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| 1 month | +5.92% | +7.71% |
| 3 months | −2.60% | −0.68% |
| 6 months | +1.69% | +6.60% |
| YTD | +2.62% | +2.65% |
| 1 year | +2.02% | +2.49% |
| 3 years (CAGR) | +13.88% | +15.79% |
| 5 years (CAGR) | — | +13.38% |
| 10 years (CAGR) | — | — |
| Since launch | +14.70% | +14.64% |
Risk
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| Volatility | 18.3% | 18.6% |
| Downside volatility | 12.5% | 12.2% |
| Sharpe | 0.40 | 0.50 |
| Sortino | 0.59 | 0.76 |
| Calmar | 0.66 | 0.76 |
| Return / risk | 0.76 | 0.85 |
| Deepest fall | −20.98% | −39.95% |
| Days to recover | 262 | 246 |
| Below its high | −3.25% | −1.13% |
Against benchmark
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| Alpha | +0.01% | — |
| Beta | 1.00 | — |
| R² | 100.0% | — |
| Up capture | 100.1% | — |
| Down capture | 100.2% | — |
| Tracking error | 0.1% | — |
| Information ratio | 0.19 | — |
| Treynor | 0.06 | — |
Consistency
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| Best 1-year | +50.21% | +100.52% |
| Middle 1-year | +7.49% | +11.62% |
| Worst 1-year | −5.89% | −38.28% |
| 1-year periods with a loss | 12.4% | 16.8% |
| Middle 3-year | +13.87% | +21.07% |
| Positive months | 66.7% | 69.4% |
| Best day | +3.97% | +4.89% |
| Worst day | −7.11% | −6.39% |
| Worst 5% day | −2.00% | −1.81% |
| Positive days | 57.2% | 56.8% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| 5-year XIRR | — | +14.13% |
| 5-year value | — | ₹8,60,995 |
| 3-year XIRR | +7.86% | +8.39% |
| 1-year XIRR | +6.12% | +8.49% |
Holdings overlap i
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| UTI Nifty Midcap 150 Exchange Traded Fund | — | 30% |
| UTI - BSE Sensex Next 50 Exchange Traded Fund | 30% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund |
|---|---|---|
| The Federal Bank Limited | 2.14% | 3.22% |
| Coforge Limited | 1.82% | 2.69% |
| The Indian Hotels Company Limited | 1.82% | 2.73% |
| One 97 Communications Limited | 1.80% | 2.67% |
| Hero MotoCorp Limited | 1.71% | 2.51% |
| Persistent Systems Limited | 1.68% | 2.50% |
| IndusInd Bank Limited | 1.41% | 2.09% |
| AU Small Finance Bank Limited | 1.28% | 1.85% |
| Lupin Limited | 1.25% | 1.85% |
| Indus Towers Limited | 1.24% | 1.86% |
| IDFC First Bank Limited | 1.22% | 1.81% |
| Info Edge (India) Limited | 1.18% | 1.73% |
| Dixon Technologies (India) Limited | 1.17% | 1.74% |
| Marico Limited | 1.08% | 1.62% |
| Ashok Leyland Limited | 1.06% | 1.55% |
| Suzlon Energy Limited | 1.05% | 1.56% |
| United Spirits Limited | 1.01% | 1.47% |
| ICICI Lombard General Insurance Company Limited | 0.98% | 1.46% |
| PB Fintech Limited | 0.91% | 1.35% |
| REC Limited | 0.91% | 1.34% |
| SRF Limited | 0.87% | 1.29% |
| Shree Cement Limited | 0.78% | 1.17% |
| Yes Bank Limited | 0.68% | 1.01% |
| Havells India Limited | 0.65% | 0.97% |
Sectors and company size
| UTI Nifty Midcap 150 Exchange Traded Fund | UTI - BSE Sensex Next 50 Exchange Traded Fund | |
|---|---|---|
| Large companies | 5.8% | 57.8% |
| Mid companies | 90.6% | 42.2% |
| Small companies | 2.5% | — |
| Top 10 holdings | 18.3% | 30.8% |
| Largest sector | Pharmaceuticals & Biotechnology 10% | Banks 15% |